RYANN RATHBONE: Open Payments
NPI 1316491368 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 28 payments from 11 companies in 2025. Trend: 2023 $1,075 · 2024 $698 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $90 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
| Corium, LLC | 2 | $42 |
| Alkermes, Inc. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Lundbeck LLC | 1 | $21 |
| OWP Pharmaceuticals, Inc. | 1 | $16 |
Products named: VRAYLAR, Auvelity, TRINTELLIX, FANAPT, SPRAVATO, Azstarys, LYBALVI, Jornay PM.
Industry payments across TX — which companies pay providers there.
